Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Probes ; 32: 46-54, 2017 04.
Article in English | MEDLINE | ID: mdl-28013042

ABSTRACT

Murine P19 embryonal carcinoma (EC) cells are convenient to differentiate into all germ layer derivatives. One of the advantages of P19 cells is that the exogenous DNA can be easily inserted into them. Here, at the first part of this study, we generated stable GFP-expressing P19 cells (P19-GFP+). FACS and western-blot analysis confirmed stable expression of GFP in the cells. We previously demonstrated the efficient induction of neuronal differentiation from mouse ES and EC cells by application of a neuroprotective drug, selegiline In the second part of this study selegiline was used to induce differentiation of P19-GFP+ into stable GFP-expressing neuron-like cells. Cresyl violet staining confirmed neuronal morphology of the differentiated cells. Furthermore, real-time PCR and immunoflourescence approved the expression of neuron specific markers. P19-GFP+ cells were able to survive, migrate and integrated into host tissues when transplanted to developing chick embryo CNS. The obtained live GFP-expressing cells can be used as an abundant source of developmentally pluripotent material for transplantation studies, investigating the cellular and molecular aspects of early differentiation.


Subject(s)
Cell Culture Techniques/methods , Embryonal Carcinoma Stem Cells/pathology , Green Fluorescent Proteins/metabolism , Neurons/metabolism , Neurons/pathology , Animals , Cell Differentiation/drug effects , Chickens , Embryonal Carcinoma Stem Cells/drug effects , Embryonal Carcinoma Stem Cells/transplantation , Fluorescence , Fluorescent Antibody Technique , Gene Expression Regulation, Neoplastic/drug effects , Mice , Neurons/drug effects , Selegiline/pharmacology , Transfection
2.
J Evid Based Complementary Altern Med ; 20(4): 302-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25818661

ABSTRACT

Addiction is a chronic and recurring disease that recurrence phenomenon is the most important challenge in treatment of this disease. Recent experiences have shown that synthetic drugs have undesirable side effects. Recent studies on medicinal plants have shown that they might be effective in treatment of different stages of addiction with lower side effects and costs. The aim of this study was to review the effects of medicinal plants in the treatment of morphine addiction in experimental animals. In this review article, by using keywords of morphine, withdrawal, and plants or herbal medicine in databases of indexing cites, desired articles were obtained since 1994. Inclusion criteria for selecting articles were the articles related to application of medicinal plants in decreasing symptoms resulting from morphine withdrawal were selected. Results of this study on experimental studies have shown that medicinal plants such as Trachyspermum copticum L and Melissa officinalis decrease the symptoms of withdrawal syndrome in a dose-dependent. Also, medicinal plants like Avena sativa, Hypericum perforatu, Passiflora incarnate, Valeriana officinalis, Satureja hortensis L, and Mentha piperita can have effects on behavior, emotions, and other problems of addicts, decreasing withdrawal symptoms. Results of this study showed that medicinal plants can be effective in controlling deprivation, decreasing dependency creation, and possibly DETOXIFICATION: of opioid addicts.


Subject(s)
Analgesics, Opioid/adverse effects , Opioid-Related Disorders/drug therapy , Plant Extracts/administration & dosage , Plants, Medicinal/chemistry , Substance Withdrawal Syndrome/drug therapy , Animals , Humans , Iran , Phytotherapy
3.
PLoS One ; 9(3): e90885, 2014.
Article in English | MEDLINE | ID: mdl-24614166

ABSTRACT

An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the generation of functional ß cells from stem cells. Embryonal carcinoma (EC) stem cells are pluripotent cells which can differentiate into all cell types. The present study was carried out to establish a simple nonselective inductive culture system for generation of IPCs from P19 EC cells by 1-2 weeks old mouse pancreas extract (MPE). Since, mouse pancreatic islets undergo further remodeling and maturation for 2-3 weeks after birth, we hypothesized that the mouse neonatal MPE contains essential factors to induce in vitro differentiation of pancreatic lineages. Pluripotency of P19 cells were first confirmed by expression analysis of stem cell markers, Oct3/4, Sox-2 and Nanog. In order to induce differentiation, the cells were cultured in a medium supplemented by different concentrations of MPE (50, 100, 200 and 300 µg/ml). The results showed that P19 cells could differentiate into IPCs and form dithizone-positive cell clusters. The generated P19-derived IPCs were immunoreactive to proinsulin, insulin and insulin receptor beta. The expression of pancreatic ß cell genes including, PDX-1, INS1 and INS2 were also confirmed. The peak response at the 100 µg/ml MPE used for investigation of EP300 and CREB1 gene expression. When stimulated with glucose, these cells synthesized and secreted insulin. Network analysis of the key transcription factors (PDX-1, EP300, CREB1) during the generation of IPCs resulted in introduction of novel regulatory candidates such as MIR17, and VEZF1 transcription factors, as well as MORN1, DKFZp761P0212, and WAC proteins. Altogether, we demonstrated the possibility of generating IPCs from undifferentiated EC cells, with the characteristics of pancreatic ß cells. The derivation of pancreatic cells from EC cells which are ES cell siblings would provide a valuable experimental tool in study of pancreatic development and function as well as rapid production of IPCs for transplantation.


Subject(s)
Cell Culture Techniques/methods , Embryonal Carcinoma Stem Cells/pathology , Insulin-Secreting Cells/metabolism , Neoplastic Stem Cells/pathology , Tissue Extracts/pharmacology , Animals , Animals, Newborn , Biomarkers/metabolism , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line, Tumor , Cell Shape/drug effects , Female , Gene Expression Regulation/drug effects , Gene Regulatory Networks/drug effects , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/drug effects , Mice, Inbred BALB C , Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/metabolism , Pluripotent Stem Cells/drug effects , Pluripotent Stem Cells/metabolism , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , Signal Transduction/genetics , Staining and Labeling , Transcription Factors/genetics , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...